Cross-Sector entity
Aerogel is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. consumer-trends accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Each carries 2 original sources on average. We currently track 2 Cross-Sector stories that mention Ozen, all published on August 12, 2026.
2 verified stories tracked
Last mentioned: Aug 12, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Aerogel is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. consumer-trends accounts for 1 of the 2 tracked stories, while 1 other category carries the remainder. Each carries 2 original sources on average. We currently track 2 Cross-Sector stories that mention Ozen, all published on August 12, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Ozen. Shared-story counts are live from our verified record — not editorial picks.
Ozen enters the sensitive-toothpaste category at a £10 premium price, armed with a novel aerogel formulation and the claimed first sensitivity patent in nearly 30 years. The launch targets a mass-market whitespace long dominated by weeks-long desensitizing formulations.
A 10-year development effort by NHS maxillofacial surgeon Dr Niall Kent produced Ozen, an aerogel-based toothpaste that seals dentinal channels and releases remineralizing ions — the first new sensitivity patent in nearly three decades. Claims of instant relief are winning endorsement from high-profile sports dentistry but remain unverified by published clinical trials.
Source: plymouthherald.co.uk · gazettelive.co.uk
